Overview

Cardiovascular Disease Risk in Women With Endometriosis

Status:
Not yet recruiting
Trial end date:
2025-08-30
Target enrollment:
Participant gender:
Summary
To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Treatments:
Ganirelix